Ultomiris 1,100 MG/11 ML vial 11ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV793
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,252
Award facts
- Contract value 100% obligated
- $28,251.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,251.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 23, 2026, for the supply of Ultomiris 1,100 mg/11 ml vials. The contract has an ultimate completion date of February 13, 2026, and represents a non-set-aside, competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (UEI: NWEGNLYTBDW4), which holds a significant indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Ultomiris, a complement inhibitor used in specialized medical treatments, exemplifies the company's role in fulfilling DLA procurement requirements for essential pharmaceutical commodities supporting military treatment facilities and federal healthcare programs. The firm fixed-price structure and expedited 21-day performance window indicate this is a time-sensitive medical supply requirement within the defense healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FV793?
SPE2DR26FV793 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FV793 worth?
The government has obligated $28,252 on SPE2DR26FV793.
Is contract SPE2DR26FV793 an order under another contract?
Yes. SPE2DR26FV793 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV793 competed?
The extent of competition for SPE2DR26FV793 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award